This Center for AIDS Research (CFAR) application underscores the intent of the University of Massachusetts Medical Center to augment existing strengths in AIDS-related research activities and to promote new ventures in AIDS-related research at the institution. The UMass CFAR application involves the participation of all investigators engaged in AIDS-related research at the institution and comprises 20 research groups with an overall total AIDS-related funding base of approximately $10M. While UMMC is applying for a CFAR for the first time, progress has been made towards ensuring preparedness at the institution in the event that a CFAR is awarded. Thus, internal and external scientific advisory panels have been established and a Web site detailing AIDS- related research activities at the institution is in place. The UMass CFAR will strengthen and promoter AIDS-research missions at the institution by increase collaboration between basic clinical and industrial researchers. CFAR activities will fall under the direction of Dr. Mario Stevenson (CFAR Director) with Dr. John Sullivan and Dr. Ron Desrosiers as CFAR Co-Directors. AIDS-related research at the institution will be enhanced through the coordinated development of CFAR-supported cores (Developmental, Clinical, Biohazard, Molecular Biology and Primate Cores). As a sign of its commitment to the establishment of a new CFAR at UMMC, the institution will provide matching funds (equivalent to one-third of direct costs awarded to the CFAR) together with new research space to support CFAR-related activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI042845-01
Application #
2595895
Study Section
Special Emphasis Panel (ZAI1-SCO-A (J1))
Project Start
1998-09-01
Project End
2002-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Foulkes-Murzycki, Jennifer E; Rosi, Christina; Kurt Yilmaz, Nese et al. (2013) Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease. ACS Chem Biol 8:513-8

Showing the most recent 10 out of 122 publications